| Kinases: Serine/threonine-specific
protein kinases |
|
|
Serine/threonine-specific
protein kinases (EC 2.7.11.1-EC 2.7.11.20) |
|
|
|
LATS1, LATS2,
MAST1, MAST2, STK38,
STK38L, CIT, ROCK1, SGK, SGK2, SGK3, Protein kinase
B ( AKT1, AKT2, AKT3), Ataxia telangiectasia
mutated, Mammalian target of
rapamycin, EIF-2
kinases ( PKR, HRI), Wee1 ( WEE1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Protein kinase C, Protein kinase Cζ, PKC alpha, PRKCB1, PRKCD, PRKCE,
PRKCH, PRKCG, PRKCI,
PRKCQ, Protein kinase
N1, PKN2, PKN3,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BRSK2, CAMK1,
CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMK4, MLCK, CASK, CHEK1, CHEK2, DAPK1, DAPK2,
DAPK3, STK11, MAPKAPK2, MAPKAPK3, MAPKAPK5, MARK1, MARK2,
MARK3, MARK4, MELK, MKNK1, MKNK2, NUAK1,
NUAK2, OBSCN, PASK, PHKG1, PHKG2, PIM1, PIM2, PKD1, PRKD2, PRKD3, PSKH1,
SNF1LK2, KIAA0999, STK40, SNF1LK, SNRK,
SPEG, TSSK2, Kalirin, TRIB1, TRIB2,
TRIB3, TRIO, Titin, DCLK1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serine/threonine-specific
protein kinases (EC 2.7.11.21-EC 2.7.11.30) |
|
|
|
|
|
|
|
CDK1, CDK2, CDKL2, CDK3, CDK4, CDK5, CDKL5, CDK6, CDK7, CDK8, CDK9, CDK10, CDC2L5, CRKRS, PCTK1,
PCTK2, PCTK3, PFTK1,
CDC2L1
|
|
|
|
|
|
|
|
Extracellular
signal-regulated ( MAPK1, MAPK3, MAPK4, MAPK6,
MAPK7, MAPK12, MAPK15), C-Jun N-terminal ( MAPK8, MAPK9, MAPK10), P38 mitogen-activated
protein ( MAPK11, MAPK13,
MAPK14)
|
|
|
|
MAP kinase kinase kinases ( MAP3K1, MAP3K2, MAP3K3, MAP3K4, MAP3K5, MAP3K6, MAP3K7, MAP3K8) RAFs
( ARAF, BRAF, KSR1, KSR2) MLKs ( MAP3K12, MAP3K13, MAP3K9, MAP3K10, MAP3K11, MAP3K7, ZAK) CDC7
|
|
|
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
Bone morphogenetic
protein receptors ( BMPR1, BMPR1A, BMPR1B, BMPR2), ACVR1,
ACVR1B, ACVR1C, ACVR2A, ACVR2B, ACVRL1, Anti-Müllerian hormone
receptor
|
|
|
|
|
|
|